Tag Archives: TSXV:APHA

Aphria Inc (APHA) Receives a Buy from Clarus

Aphria Inc (APHA – Research Report), the Healthcare company, has received a rating update from a Wall Street analyst today. The company received a Buy rating from Clarus’ analyst Noel Atkinson, with a C$22.75 price target. Atkinson noted: “We had